- Following treatment for lung cancer, the majority of patients rated QoL and independence as more important than survival and disease recurrence.
Why this matters
- Nearly half of the patients said they would have preferred a different treatment from the one they received.
- 114 patients with stage I lung cancer were surveyed 4-6 months after treatment with stereotactic body radiation therapy (SBRT; 60%) or surgery (40%).
- Funding: Portland Veterans Affairs Medical Center.
- The 4 values ranked as most important were remaining at home (75%), the ability to care for oneself (66%), additional years of life (55%), and risk of recurrence (44%).
- 83% would accept a 2% chance of periprocedural mortality for 1 additional year of life (89% in SBRT group and 74% in surgery group).
- 64% would accept a 10% chance of periprocedural mortality for 1 additional year of life and 52% would accept a 20% chance of periprocedural death for 1 additional year of life.
- Overall, 49% said they would have preferred a different treatment from the one they received.
- Treatment concordance lower in SBRT group (32%) vs surgery group (81%).
- Patients could not add concerns outside those on the survey.